1. Home
  2. GCTK vs SDSTW Comparison

GCTK vs SDSTW Comparison

Compare GCTK & SDSTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GCTK
  • SDSTW
  • Stock Information
  • Founded
  • GCTK 2001
  • SDSTW N/A
  • Country
  • GCTK United States
  • SDSTW United States
  • Employees
  • GCTK N/A
  • SDSTW 8
  • Industry
  • GCTK Medical/Dental Instruments
  • SDSTW
  • Sector
  • GCTK Health Care
  • SDSTW
  • Exchange
  • GCTK Nasdaq
  • SDSTW Nasdaq
  • Market Cap
  • GCTK 3.3M
  • SDSTW 3.8M
  • IPO Year
  • GCTK N/A
  • SDSTW N/A
  • Fundamental
  • Price
  • GCTK $4.49
  • SDSTW $0.07
  • Analyst Decision
  • GCTK
  • SDSTW
  • Analyst Count
  • GCTK 0
  • SDSTW 0
  • Target Price
  • GCTK N/A
  • SDSTW N/A
  • AVG Volume (30 Days)
  • GCTK 483.3K
  • SDSTW 41.6K
  • Earning Date
  • GCTK 08-14-2025
  • SDSTW 03-26-2025
  • Dividend Yield
  • GCTK N/A
  • SDSTW N/A
  • EPS Growth
  • GCTK N/A
  • SDSTW N/A
  • EPS
  • GCTK N/A
  • SDSTW N/A
  • Revenue
  • GCTK N/A
  • SDSTW N/A
  • Revenue This Year
  • GCTK N/A
  • SDSTW N/A
  • Revenue Next Year
  • GCTK N/A
  • SDSTW N/A
  • P/E Ratio
  • GCTK N/A
  • SDSTW N/A
  • Revenue Growth
  • GCTK N/A
  • SDSTW N/A
  • 52 Week Low
  • GCTK $4.22
  • SDSTW $0.10
  • 52 Week High
  • GCTK $3,756.00
  • SDSTW $0.12
  • Technical
  • Relative Strength Index (RSI)
  • GCTK 38.42
  • SDSTW N/A
  • Support Level
  • GCTK $4.70
  • SDSTW N/A
  • Resistance Level
  • GCTK $5.88
  • SDSTW N/A
  • Average True Range (ATR)
  • GCTK 0.46
  • SDSTW 0.00
  • MACD
  • GCTK 0.02
  • SDSTW 0.00
  • Stochastic Oscillator
  • GCTK 16.27
  • SDSTW 0.00

About GCTK GlucoTrack Inc.

GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.

About SDSTW Stardust Power Inc. Warrant

Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).

Share on Social Networks: